GENE ONLINE|News &
Opinion
Blog

Acute Myeloid Leukemia
Senti Bio Wins FDA RMAT Designation for SENTI-202 on 50% Response Rate in Leukemia Trial
2025-12-11
Machine Learning Identifies Gene Mutations in Leukemia Cells Through Image Analysis
2025-03-14
AML
A $230M Deal for New Leukemia Drug Awaits FDA
2022-08-03
As BIO 2021 Approaches, Taiwan’s DCB Reveals Competitive Bio-Innovations to Watch Out For
2021-06-11
Bluebird Bio Temporarily Suspends Sickle Cell Trials Following Cancer Diagnosis in Two Patients
2021-02-18
FDA Approves Venetoclax Combination for New Acute Myeloid Leukemia Cases
2020-10-19
Bristol Myers Squibb Notches Key Regulatory Win for Oral Formulation of Epigenetic Modifier
2020-09-06
Bristol-Myers-Squibb Anticipates FDA Approval for CC-486 as a Treatment for Acute Myeloid Leukemia
2020-08-30
ASGCT20: Intellia Presents Data on Two of its CRISPR-Based Novel Therapeutic Candidates
2020-05-16
Gilead Strikes US$ 4.9B Takeover Deal of Forty Seven
2020-03-02
Weekly in Asia|Oct-2
2019-10-23
Weekly in Asia 20190602-0608
2019-06-11
Gilteritinib becomes first FLT3 targeted therapy for relapsed AML
2018-12-04
LATEST
Phosphorylation and Ubiquitination Mechanisms Linked to Rosacea Pathogenesis
2026-10-10
Malin and Goetz Updates SPF 30 Mineral Sunscreen Documentation on DailyMed
2026-10-09
Henry Schein Updates Vitamin A & D Ointment Product Documentation on DailyMed
2026-10-09
Mary Kay Updates Clear Proof Acne Treatment Gel Labeling in DailyMed Database
2026-10-09
Dechra Veterinary Products Updates Muricin Ointment Documentation on DailyMed
2026-10-09
Cardinal Health Updates LEADER Daily Moisturizer Product Documentation on DailyMed
2026-10-09
S.S.S. Company Updates Curasore Pramoxine Hydrochloride Product Information on DailyMed
2026-10-09
EVENT
Scroll to Top